14 May 2026
5 months ago
948 views
A new pharmacist role in Dunedin Hospital’s Emergency Department has improved patient flow and safety by taking medication histories, reviewing medicines, and identifying issues early, saving doctors up to 20 minutes per patient. This role enables faster, more accurate clinical decisions and allows doctors to focus more on patient care rather than paperwork, enhancing efficiency across the hospital. Positive feedback from ED doctors highlights the role as a game changer, particularly for patients with complex medication needs, demonstrating the benefits of targeted workforce initiatives.
13 May 2026
5 months ago
1222 views
Te Kūiti Hospital has launched a new infusion service providing local cancer treatments, reducing the need for patients to travel to Waikato Hospital. Initially operating one day a week with certified staff and on-site support, the service aims to expand as part of a nationwide effort to increase cancer treatment access in rural communities. Supported by significant government investment, this initiative focuses on patient-centered care, improving timely treatment access, and enhancing the overall experience for patients and their families.
10 May 2026
5 months ago
893 views
A new community-based cancer infusion centre is opening in Henderson, West Auckland, allowing patients to receive treatment closer to home and reducing travel to Auckland City Hospital. This service, operating five days a week with four treatment chairs, complements a recent infusion centre at Waitākere Hospital and is part of a nationwide effort to expand community cancer care. Supported by a $210 million investment from Budget 2024 and increased Pharmac funding, New Zealand plans to open 14 new infusion centres and expand 14 others to meet growing demand and improve patient access.
07 May 2026
5 months ago
959 views
Health Minister Simeon Brown has welcomed the ratification of a new collective agreement for approximately 5,500 senior doctors represented by the Association of Salaried Medical Specialists (ASMS). He emphasized the critical role senior doctors play in the healthcare system and their contribution to achieving government health targets. The agreement follows similar approvals for other health sector groups and reflects constructive engagement between ASMS and Health New Zealand to ensure continued patient care.
15 Apr 2026
6 months ago
1232 views
From June, New Zealand will expand funded treatment services through community pharmacies to provide easier and more affordable care for children’s common health conditions, reducing reliance on GP appointments. Pharmacists will be authorized to assess patients and supply subsidized medicines for issues like pain, fever, scabies, and urinary tract infections, supported by a $5 million annual fund to ensure nationwide availability. This initiative aims to improve timely access to healthcare, especially in rural and underserved areas, by leveraging pharmacists as accessible and trusted health professionals.
13 Apr 2026
6 months ago
1189 views
New Zealand is expanding community infusion services with 14 new centres and 14 expansions to provide thousands more cancer treatments closer to patients’ homes, supported by a $210 million investment from Budget 2024. This initiative responds to a 12% increase in demand, adding 218 more chair-days weekly and addressing the need for increased capacity following the introduction of 33 new cancer medicines funded by Pharmac. The government aims to improve cancer outcomes by ensuring timely, accessible treatment nationwide, while recruiting additional healthcare staff to support the expanded services through 2028.
09 Apr 2026
6 months ago
1182 views
Associate Health Minister David Seymour applauds Pharmac’s decision to fund two new combination therapies—venetoclax with ibrutinib or obinutuzumab—as first-line treatments for chronic lymphocytic leukaemia (CLL), along with expanded access to ibrutinib as a second-line option. These treatments, available from May 2026, aim to improve patient outcomes by enabling longer remission, reducing the need for chemotherapy and hospital visits, and accommodating patient feedback gathered through community consultation. Since the government increased Pharmac’s budget, over 200,000 patients have benefited from funding decisions on 133 medicines, including 46 cancer treatments, reflecting a more collaborative approach with the patient community.
31 Mar 2026
6 months ago
1184 views
New legislation requires the Treasury to include specific fiscal risk statements in economic and fiscal updates, addressing previously unclear risks such as time-limited funding for Pharmac medicines. The Act removes the requirement for Treasury to report on wellbeing, focusing instead on core economic and fiscal advice, and advances the delivery date of the Pre-Election Economic and Fiscal Update by five working days to better inform voters. This law will take effect on July 1, 2026.
31 Mar 2026
6 months ago
1119 views
New legislation requires the Treasury's economic and fiscal updates to include specific statements on fiscal risks, addressing previous omissions like time-limited funding for essential medicines. It also removes the Treasury's obligation to report on "wellbeing," refocusing its role on core economic and fiscal advice, and advances the delivery date of the Pre-Election Economic and Fiscal Update to give voters more time to consider election choices. The Act is set to take effect by July 1, 2026.
31 Mar 2026
6 months ago
1204 views
Associate Health Minister David Seymour welcomes Pharmac’s decision to fund Trikafta and Alyftrek for all children with cystic fibrosis regardless of age from April 1, 2026, expanding access beyond the previous age limits. Pharmac will also widen access to Kalydeco for all eligible patients and allow doctors to prescribe these lifechanging treatments based on clinical judgment, addressing the urgent needs of young children affected by cystic fibrosis. This decision follows positive public consultation and reflects Pharmac’s commitment to working with the cystic fibrosis community to improve health outcomes and reduce pressure on the health system.
26 Mar 2026
7 months ago
1235 views
Pharmac has proposed a provisional agreement with Medtronic New Zealand to supply 65% of drug-eluting stents to public hospitals, potentially saving $1.2 million annually while ensuring access to high-quality stents. The proposal, developed with input from the Interventional Cardiology Advisory Group, aims to improve procurement efficiency and collaboration between Pharmac and Health New Zealand. Public consultation is open until April 28 to gather feedback from healthcare professionals and stakeholders before finalizing the deal for implementation starting June 2026.
12 Mar 2026
7 months ago
1208 views
The Government plans to transfer funding responsibility for ambulance medicines from Health New Zealand and ACC to Pharmac to improve procurement efficiency, ensure nationwide access to consistent emergency medicines, and save costs. This change will create a single nationally consistent medicine list for ambulance services, enhancing continuity of care between ambulance providers and hospitals while leveraging Pharmac’s expertise and buying power. Public consultation on the proposal is open from March 12 to April 2, 2024, with implementation targeted for July 1, 2026.
11 Mar 2026
7 months ago
1229 views
Anna Adams has been appointed Solicitor-General and Chief Executive of the Crown Law Office, bringing 28 years of extensive public law experience and strong private-sector leadership. She has acted as lead counsel in over 100 significant cases and held senior roles at Meredith Connell and PHARMAC. Her appointment, effective from 11 May 2026 for five years, is praised for her judgment, integrity, and ability to provide strong leadership in this key constitutional role.
05 Mar 2026
7 months ago
1160 views
Associate Health Minister David Seymour and Health Minister Simeon Brown support Pharmac’s proposal to fund letermovir from May 2026 to prevent serious CMV infections in stem cell transplant patients and those with severe immunosuppression. This initiative aims to improve patient outcomes by reducing complications, hospital stays, and healthcare system pressure, aligning with the Government’s commitment to expanding stem cell transplant capacity and enhancing cancer treatment access. Pharmac is currently seeking public feedback on the proposal, inviting input from affected patients, families, health professionals, and advocacy groups.
02 Mar 2026
7 months ago
1335 views
Health Minister Simeon Brown has welcomed the ratification of new collective agreements for approximately 3,500 Public Health and Mental Health Nurses in New Zealand, which include salary increases, lump sum payments, and enhanced professional development allowances. The agreements also commit to recruiting over 550 additional nursing positions to strengthen frontline services. This follows recent approvals of agreements for other health sector workers, highlighting collaborative efforts to ensure staff support and quality care for New Zealanders.